Emergent BioSolutions | Capital Social E Reservas



Capital Social e Reservas Alterar Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Akebia Therapeutics USD 41.59M 12.37M 2025-09
ALKERMES USD 1.73B 108.85M 2025-09
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 458.89M 6.03M 2025-09
ANI Pharmaceuticals USD 505.82M 69.06M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Coherus Biosciences USD 87.77M 32.05M 2025-09
Exact Sciences USD 2.5B 32M 2025-09
Exelixis USD 2.16B 619K 2025-12
Glaxosmithkline GBP 21.7B 7.35B 2025-09
Heron Therapeutics USD 14.88M 42.14M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Lexicon Pharmaceuticals USD 129.44M 6.41M 2025-06
Lonza CHF 9.33B 23M 2024-12
Merck USD 51.85B 2.79B 2025-09
Moderna USD 9.33B 69M 2025-09
Myriad Genetics USD 372.8M 15.3M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Pacira USD 727.21M 30.55M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Xoma USD 87.94M 15.5M 2025-09


Emergent BioSolutions Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.